IMC-Chicago, LLC - SAGE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 6 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$705,894
-46.3%
34,300
+125.7%
0.00%
-50.0%
Q4 2020$1,315,000
-9.6%
15,200
-36.1%
0.00%0.0%
Q3 2020$1,455,000
-10.4%
23,800
+5.8%
0.00%
-50.0%
Q4 2019$1,624,000
+126.2%
22,500
+200.0%
0.00%
+100.0%
Q4 2018$718,000–7,500–0.00%–
 Download
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 76$657,0000.02%
GROUP ONE TRADING, L.P. 66,700$5,770,0000.01%
SIMPLEX TRADING, LLC 275$2,379,0000.00%
IMC-Chicago, LLC 15,200$1,315,0000.00%
JPMORGAN CHASE & CO 44,200$3,824,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAGE THERAPEUTICS INC shareholders